Biosimilars Access and Affordability Act
Official title: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
What Do You Think?
How would you vote?
Referandom Vote
Vote to see the result.
How Congress Voted
PendingWhat Happened in Congress?
Not yet voted on the floor.
Where the Bill Stands
- Introduced, done
- Committee, current stage
- Floor Vote, not yet
- Outcome, not yet
Sponsors
Related Documents
Timeline
- Library of CongressIntroduced in Senate
- SenateRead twice and referred to the Committee on Finance.
- Introduced
- Committee

Comments
Comments with insults, hate speech or personal information are removed.